Proxy Votes Now

Home › Funds › T. Rowe Price › T. Rowe Price Tax-Efficient Equity Fund

T. Rowe Price Tax-Efficient Equity Fund (PREFX) proxy voting record 2025-2026

Fund family: T. Rowe Price · Filed by T. Rowe Price Tax-Efficient Funds, Inc. (CIK 1038490) · SEC series S000002160

Share classes and tickers: PREFX (C000005556), TEEFX (C000193192)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 3,576 with, 132 against, 0 abstentions (not counted as with management); 5 items carried no recommendation. Shareholder proposals: 25 FOR, 109 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with T. Rowe Price as a whole

The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsT. Rowe PriceItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)86.9%3,46493.7%208,710
Backed environmental and social shareholder proposals at US companies0.0%612.6%3,333

Where this fund voted differently from most T. Rowe Price funds

Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most T. Rowe Price funds on 239 items (6.6% of the 3,609 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
Microsoft Corporation2025-12-05Advisory Vote to Approve Named Executive Officer Compensation ("say-on-pay vote")AgainstFOR — 49 of 49 T. Rowe Price fundsAgainstPassed (calculated), 91.9% support
Apple Inc.2026-02-24Advisory vote to approve executive compensationAgainstFOR — 42 of 42 T. Rowe Price fundsAgainstApproved, 91.4% support
NVIDIA Corporation2026-06-24Advisory approval of our executive compensation.AgainstFOR — 44 of 44 T. Rowe Price fundsAgainstApproved, 93.6% support
Meta Platforms, Inc.2026-05-27Shareholder A shareholder proposal regarding annual vote regarding executive pay.AgainstFOR — 43 of 43 T. Rowe Price fundsForNot approved, 27.1% support
Meta Platforms, Inc.2026-05-27Election of Directors: Dana WhiteWithholdFOR — 42 of 42 T. Rowe Price fundsAgainstElected, 91.4% support
Eli Lilly and Company2026-05-04Approval, on an advisory basis, of the compensation paid to the company's named executive officers.AgainstFOR — 45 of 45 T. Rowe Price fundsAgainstApproved, 96.0% support
Advanced Micro Devices, Inc.2026-05-13Approve on a non-binding, advisory basis the compensation of the named executive officers, as disclosed in the proxy statement pursuant to the compensation disclosure rules of the U.S. Securities and Exchange Commission.AgainstFOR — 43 of 43 T. Rowe Price fundsAgainstApproved, 92.6% support
UnitedHealth Group Incorporated2026-06-01Advisory approval of the Company's executive compensation.AgainstFOR — 45 of 45 T. Rowe Price fundsAgainstApproved, 82.6% support
GE Aerospace2026-05-05Advisory Approval of Our Named Executives' CompensationAgainstFOR — 42 of 42 T. Rowe Price fundsAgainst—
Visa Inc.2026-01-27To approve, on an advisory basis, the compensation paid to our named executive officers.AgainstFOR — 39 of 39 T. Rowe Price fundsAgainstApproved, 93.5% support
Mastercard Incorporated2026-06-16Advisory approval of Mastercard's executive compensationAgainstFOR — 40 of 40 T. Rowe Price fundsAgainstApproved, 94.9% support
UnitedHealth Group Incorporated2026-06-01Shareholder If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent.ForAGAINST — 40 of 40 T. Rowe Price fundsAgainstNot approved, 20.3% support
Morgan Stanley2026-05-14To approve the compensation of executives as disclosed in the proxy statement (non-binding advisory vote)AgainstFOR — 38 of 38 T. Rowe Price fundsAgainstPassed (calculated), 95.8% support
Netflix, Inc.2026-06-04Advisory approval of named executive officer compensation.AgainstFOR — 39 of 39 T. Rowe Price fundsAgainstApproved, 83.7% support
Visa Inc.2026-01-27Shareholder Shareholder proposal requesting the Board of Directors to adopt a policy for an independent chair.ForAGAINST — 34 of 34 T. Rowe Price fundsAgainstNot approved, 16.2% support
The Home Depot, Inc.2026-05-21Advisory Vote to Approve Executive Compensation ("Say-on-Pay")AgainstFOR — 34 of 34 T. Rowe Price fundsAgainstApproved, 93.8% support
Philip Morris International Inc.2026-05-06Advisory Vote Approving Executive CompensationAgainstFOR — 36 of 36 T. Rowe Price fundsAgainstApproved, 95.9% support
Linde Plc2025-07-29To approve, on an advisory and non-binding basis, the compensation of Linde plc's Named Executive Officers, as disclosed in the 2025 Proxy statement.AgainstFOR — 34 of 34 T. Rowe Price fundsAgainstApproved, 94.1% support
Intuitive Surgical, Inc.2026-04-30To approve, by advisory vote, the compensation of the Company's Named Executive Officers.AgainstFOR — 34 of 34 T. Rowe Price fundsAgainstApproved, 94.0% support
Booking Holdings Inc.2026-06-02Advisory vote to approve 2025 executive compensation.AgainstFOR — 34 of 34 T. Rowe Price fundsAgainstApproved, 90.2% support
CME Group Inc.2026-06-09Advisory vote on the compensation of our named executive officers.AgainstFOR — 33 of 33 T. Rowe Price fundsAgainst—
Marsh & McLennan Companies, Inc.2026-05-21Advisory (Nonbinding) Vote to Approve Named Executive Officer CompensationAgainstFOR — 35 of 35 T. Rowe Price fundsAgainstApproved, 88.5% support
Tesla, Inc.2025-11-06A Tesla proposal for a non-binding advisory vote approving 2024 executive compensation.AgainstFOR — 32 of 32 T. Rowe Price fundsAgainstApproved, 78.7% support
Deere & Company2026-02-25Advisory vote to approve executive compensation ("say-on-pay")AgainstFOR — 31 of 31 T. Rowe Price fundsAgainstApproved, 92.2% support
ServiceNow, Inc.2026-05-21Advisory vote to approve ServiceNow's named executive officer compensation.AgainstFOR — 31 of 31 T. Rowe Price fundsAgainstPassed (calculated), 85.5% support
Show all 239
Items 26 to 239.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
Amazon.com, Inc.2026-05-20Shareholder SHAREHOLDER PROPOSAL REQUESTING A MANDATORY INDEPENDENT BOARD CHAIR POLICYForAGAINST — 41 of 42 T. Rowe Price fundsAgainstNot approved, 14.2% support
Tesla, Inc.2025-11-06A Tesla proposal for approval of the A&R 2019 Equity Incentive Plan.AgainstFOR — 28 of 28 T. Rowe Price fundsAgainstApproved, 79.1% support
Tesla, Inc.2025-11-06A Tesla proposal to elect three Class III directors to serve for a term of three years, or until their respective successors are duly elected and qualified: Joe GebbiaAgainstFOR — 28 of 28 T. Rowe Price fundsAgainstElected, 87.3% support
Tesla, Inc.2025-11-06A Tesla proposal to elect three Class III directors to serve for a term of three years, or until their respective successors are duly elected and qualified: Kathleen Wilson-ThompsonAgainstFOR — 28 of 28 T. Rowe Price fundsAgainstElected, 78.4% support
GE Vernova Inc.2026-05-20Approve the compensation of our named executive officers in an advisory voteAgainstFOR — 28 of 28 T. Rowe Price fundsAgainstApproved, 96.0% support
Amphenol Corporation2026-05-21Advisory vote to approve compensation of named executive officersAgainstFOR — 28 of 28 T. Rowe Price fundsAgainst—
Analog Devices, Inc.2026-03-11Advisory vote to approve the compensation of our named executive officers.AgainstFOR — 28 of 28 T. Rowe Price fundsAgainstApproved, 90.3% support
The TJX Companies, Inc.2026-06-09Advisory approval of TJX's executive compensation (the say-on-pay vote)AgainstFOR — 25 of 25 T. Rowe Price fundsAgainstApproved, 92.8% support
The Sherwin-Williams Company2026-04-22Advisory Approval of the Compensation of the Named Executive OfficersAgainstFOR — 26 of 26 T. Rowe Price fundsAgainstApproved, 92.2% support
TransDigm Group Incorporated2026-03-05Approval, on an advisory basis, of the compensation of our named executive officers.AgainstFOR — 25 of 25 T. Rowe Price fundsAgainstPassed (calculated), 96.8% support
TE Connectivity plc2026-03-11An advisory vote to approve named executive officer compensation.AgainstFOR — 39 of 40 T. Rowe Price fundsAgainstPassed (calculated), 92.1% support
Walmart Inc.2026-06-04Advisory Vote to Approve Named Executive Officer CompensationAgainstFOR — 23 of 23 T. Rowe Price fundsAgainstPassed (calculated), 96.1% support
Palantir Technologies Inc.2026-06-03Shareholder Stockholder proposal entitled "Political Spending Disclosure," if properly presented at the Annual Meeting.AgainstFOR — 23 of 23 T. Rowe Price fundsForNot approved, 26.2% support
The Progressive Corporation2026-05-08Cast an advisory vote to approve our executive compensation program;AgainstFOR — 24 of 24 T. Rowe Price fundsAgainst—
McKesson Corporation2025-07-30Advisory Vote to Approve the Company's Executive CompensationAgainstFOR — 23 of 23 T. Rowe Price fundsAgainstApproved, 92.0% support
AppLovin Corporation2026-06-03Approval of an amendment to our amended and restated certificate of incorporation to provide for officer exculpation as permitted by Delaware law.AgainstFOR — 23 of 23 T. Rowe Price fundsAgainstApproved, 90.1% support
Intuit Inc.2026-01-22Advisory vote to approve Intuit's executive compensation (say-on-pay)AgainstFOR — 23 of 23 T. Rowe Price fundsAgainstPassed (calculated), 93.2% support
Moody's Corporation2026-04-14Advisory resolution approving executive compensation.AgainstFOR — 23 of 23 T. Rowe Price fundsAgainstApproved, 96.6% support
Northrop Grumman Corporation2026-05-20Proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers.AgainstFOR — 24 of 24 T. Rowe Price fundsAgainstApproved, 95.4% support
Cencora, Inc.2026-03-05Advisory vote to approve the fiscal 2025 compensation of Cencora, Inc.'s named executive officers.AgainstFOR — 35 of 36 T. Rowe Price fundsAgainstApproved, 93.2% support
TechnipFMC plc2026-05-012025 U.S. Say-on-Pay for Named Executive Officers: To approve, as a non-binding advisory resolution, the Company's named executive officer compensation for the year ended December 31, 2025, as reported in the Company's Proxy Statement.AgainstFOR — 35 of 36 T. Rowe Price fundsAgainst—
Morgan Stanley2026-05-14Shareholder Shareholder proposal requesting an independent Board ChairmanForAGAINST — 32 of 33 T. Rowe Price fundsAgainstFailed (calculated), 27.3% support
QUALCOMM Incorporated2026-03-17Approval, on an advisory basis, of the compensation of our named executive officers.AgainstFOR — 21 of 21 T. Rowe Price fundsAgainstApproved, 91.8% support
KLA Corporation2025-11-05To approve on a non-binding, advisory basis our named executive officer compensation.AgainstFOR — 21 of 21 T. Rowe Price fundsAgainstApproved, 92.4% support
The Boeing Company2026-04-17Approve, on an Advisory Basis, Named Executive Officer Compensation.AgainstFOR — 22 of 22 T. Rowe Price fundsAgainstPassed (calculated), 89.7% support
Parker-Hannifin Corporation2025-10-22Approval of, on a non-binding, advisory basis, the compensation of our Named Executive Officers.AgainstFOR — 22 of 22 T. Rowe Price fundsAgainstApproved, 88.0% support
Synopsys, Inc.2026-04-16To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the attached Proxy Statement.AgainstFOR — 22 of 22 T. Rowe Price fundsAgainstApproved, 91.5% support
The Allstate Corporation2026-05-22Advisory vote to approve the compensation of the named executives.AgainstFOR — 32 of 33 T. Rowe Price fundsAgainstPassed (calculated), 92.7% support
Monolithic Power Systems, Inc.2026-06-11Approve, on an advisory basis, the 2025 executive compensation.AgainstFOR — 32 of 33 T. Rowe Price fundsAgainstPassed (calculated), 96.8% support
Spotify Technology SA2026-04-15Approve Remuneration of DirectorsAgainstFOR — 20 of 20 T. Rowe Price fundsAgainst—
TechnipFMC plc2026-05-012025 U.K. Directors' Remuneration Report: To approve, as a non-binding advisory resolution, the Company's directors' remuneration report for the year ended December 31, 2025, as reported in the Company's U.K. Annual Report and Accounts.AgainstFOR — 30 of 31 T. Rowe Price fundsAgainst—
PTC Inc.2026-02-11Advisory vote to approve the compensation of our named executive officers (say-on-pay).AgainstFOR — 30 of 31 T. Rowe Price fundsAgainst—
Broadcom Inc.2026-04-20Advisory vote to approve the named executive officer compensation.AgainstFOR — 46 of 49 T. Rowe Price fundsAgainstApproved, 66.4% support
The Home Depot, Inc.2026-05-21Shareholder Shareholder Proposal Regarding Independent Board ChairForAGAINST — 28 of 29 T. Rowe Price fundsAgainstNot approved, 26.0% support
Ross Stores, Inc.2026-05-20Advisory vote to approve the resolution on the compensation of the named executive officers.AgainstFOR — 29 of 30 T. Rowe Price fundsAgainstPassed (calculated), 92.6% support
Natera, Inc.2026-06-11To approve an amendment to Natera's 2015 Equity Incentive Plan, as amended and restated.AgainstFOR — 29 of 30 T. Rowe Price fundsAgainstPassed (calculated), 78.1% support
Chipotle Mexican Grill, Inc.2026-06-11An advisory vote to approve the compensation of our executive officers as disclosed in the proxy statement ("say on pay").AgainstFOR — 29 of 30 T. Rowe Price fundsAgainstApproved, 95.3% support
Tradeweb Markets Inc.2026-05-19To approve, on an advisory basis, the compensation of our named executive officers.AgainstFOR — 28 of 29 T. Rowe Price fundsAgainstApproved, 98.7% support
Tenet Healthcare Corporation2026-05-27To vote, on an advisory basis, to approve the Company's executive compensation.AgainstFOR — 28 of 29 T. Rowe Price fundsAgainst—
Accenture Plc2026-01-28To approve, in a non-binding vote, the compensation of our named executive officers.AgainstFOR — 18 of 18 T. Rowe Price fundsAgainst—
Vertex Pharmaceuticals Incorporated2026-05-13Advisory vote to approve named executive officer compensation.AgainstFOR — 17 of 17 T. Rowe Price fundsAgainstApproved, 93.5% support
Corning Incorporated2026-04-30Advisory approval of our executive compensation (Say on Pay)AgainstFOR — 18 of 18 T. Rowe Price fundsAgainstPassed (calculated), 94.0% support
Motorola Solutions, Inc.2026-05-18Advisory Approval of the Company's Executive Compensation.AgainstFOR — 17 of 17 T. Rowe Price fundsAgainstApproved, 91.5% support
Packaging Corporation of America2026-05-12Proposal to approve our executive compensation.AgainstFOR — 26 of 27 T. Rowe Price fundsAgainst—
Carvana Co.2026-05-05Shareholder To vote upon one stockholder proposal, as described in the Proxy Statement.ForAGAINST — 25 of 26 T. Rowe Price fundsAgainstNot approved, 3.9% support
Datadog, Inc.2026-06-15Advisory vote to approve the compensation of our named executive officers.AgainstFOR — 25 of 26 T. Rowe Price fundsAgainstApproved, 95.9% support
Ulta Beauty, Inc.2026-06-09Advisory resolution to approve the Company's executive compensation.AgainstFOR — 25 of 26 T. Rowe Price fundsAgainstApproved, 77.9% support
Equifax Inc.2026-05-07Advisory vote to approve named executive officer compensation ("say-on-pay").AgainstFOR — 25 of 26 T. Rowe Price fundsAgainstApproved, 84.3% support
BrightSpring Health Services, Inc.2026-05-21Advisory vote on executive compensationAgainstFOR — 25 of 26 T. Rowe Price fundsAgainstApproved, 98.7% support
Vaxcyte, Inc.2026-06-15Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.AgainstFOR — 25 of 26 T. Rowe Price fundsAgainstApproved, 97.9% support
Palo Alto Networks, Inc.2025-12-09To approve, on an advisory basis, the compensation of our named executive officers.AgainstFOR — 15 of 15 T. Rowe Price fundsAgainstFailed (calculated), 46.6% support
Hilton Worldwide Holdings Inc.2026-05-14Approval, in a non-binding advisory vote, of the compensation paid to the named executive officers.AgainstFOR — 24 of 25 T. Rowe Price fundsAgainstApproved, 92.6% support
Vertiv Holdings Co.2026-06-17To approve, on an advisory basis, the 2025 compensation of our named executive officers as disclosed in the Proxy Statement.AgainstFOR — 24 of 25 T. Rowe Price fundsAgainstApproved, 88.4% support
Quest Diagnostics Incorporated2026-05-20An advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 proxy statement.AgainstFOR — 24 of 25 T. Rowe Price fundsAgainstApproved, 92.4% support
HubSpot, Inc.2026-06-15Non-binding advisory vote to approve the compensation of the Company's named executive officers;AgainstFOR — 24 of 25 T. Rowe Price fundsAgainstApproved, 90.2% support
Repligen Corporation2026-05-14Election of Directors: Carrie Eglinton MannerAgainstFOR — 22 of 23 T. Rowe Price fundsAgainstElected, 81.0% support
Repligen Corporation2026-05-14Election of Directors: Glenn P. MuirAgainstFOR — 22 of 23 T. Rowe Price fundsAgainstElected, 74.4% support
Repligen Corporation2026-05-14Election of Directors: Karen A. DawesAgainstFOR — 22 of 23 T. Rowe Price fundsAgainstElected, 82.4% support
BlackRock, Inc.2026-05-20Approval, in a non-binding advisory vote, of the compensation for named executive officers.AgainstFOR — 14 of 14 T. Rowe Price fundsAgainstPassed (calculated), 65.0% support
Automatic Data Processing, Inc.2025-11-12Advisory Vote on Executive Compensation.AgainstFOR — 14 of 14 T. Rowe Price fundsAgainstApproved, 91.8% support
Vertiv Holdings Co.2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: David M. CoteWithholdFOR — 21 of 22 T. Rowe Price fundsAgainstPassed (calculated), 90.4% support
Vertiv Holdings Co.2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Edward L. MonserWithholdFOR — 21 of 22 T. Rowe Price fundsAgainstPassed (calculated), 82.9% support
Vertiv Holdings Co.2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Giordano AlbertazziWithholdFOR — 21 of 22 T. Rowe Price fundsAgainstPassed (calculated), 97.5% support
Vertiv Holdings Co.2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Jakki L. HausslerWithholdFOR — 21 of 22 T. Rowe Price fundsAgainstPassed (calculated), 96.0% support
Vertiv Holdings Co.2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Joseph J. DeAngeloWithholdFOR — 21 of 22 T. Rowe Price fundsAgainstPassed (calculated), 74.9% support
Vertiv Holdings Co.2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Roger FradinWithholdFOR — 21 of 22 T. Rowe Price fundsAgainstPassed (calculated), 70.3% support
Vertiv Holdings Co.2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Steven S. ReinemundWithholdFOR — 21 of 22 T. Rowe Price fundsAgainstPassed (calculated), 76.6% support
Boston Scientific Corporation2026-04-30To approve, on a non-binding, advisory basis, the compensation of our named executive officers.AgainstFOR — 14 of 14 T. Rowe Price fundsAgainstApproved, 90.8% support
Zoetis Inc.2026-05-20Advisory vote to approve our executive compensation.AgainstFOR — 14 of 14 T. Rowe Price fundsAgainstApproved, 85.6% support
Micron Technology, Inc.2026-01-15PROPOSAL BY THE COMPANY TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DESCRIBED IN THE PROXY STATEMENT.AgainstFOR — 13 of 13 T. Rowe Price fundsAgainstApproved, 95.1% support
Trane Technologies plc2026-06-04Advisory approval of the compensation of the Company's named executive officers.AgainstFOR — 13 of 13 T. Rowe Price fundsAgainstPassed (calculated), 88.4% support
Cadence Design Systems, Inc.2026-05-07ADVISORY RESOLUTION TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATIONAgainstFOR — 13 of 13 T. Rowe Price fundsAgainstApproved, 86.9% support
Cheniere Energy, Inc.2026-05-14Approve, on an advisory and non-binding basis, the compensation of the Company's named executive officers for 2025.AgainstFOR — 20 of 21 T. Rowe Price fundsAgainstPassed (calculated), 90.7% support
Ventas, Inc.2026-05-13Approval, on an advisory basis, of the compensation of named executive officers of Ventas, Inc.AgainstFOR — 20 of 21 T. Rowe Price fundsAgainstPassed (calculated), 91.7% support
Quest Diagnostics Incorporated2026-05-20Shareholder Stockholder proposal regarding an independent board chairman, if properly presented at the Annual Meeting.ForAGAINST — 20 of 21 T. Rowe Price fundsAgainstNot approved, 25.6% support
Broadridge Financial Solutions, Inc.2025-11-13Advisory vote to approve the compensation of the Company's Named Executive Officers (the Say on Pay Vote);AgainstFOR — 20 of 21 T. Rowe Price fundsAgainstPassed (calculated), 91.6% support
Elanco Animal Health Incorporated2026-05-21Advisory vote on the compensation of the company's named executive officers.AgainstFOR — 20 of 21 T. Rowe Price fundsAgainstApproved, 82.0% support
Ecolab Inc.2026-05-07Approve, on an advisory basis, the compensation of our named executive officers disclosed in the Proxy Statement.AgainstFOR — 12 of 12 T. Rowe Price fundsAgainstApproved, 94.0% support
Northrop Grumman Corporation2026-05-20Shareholder Shareholder proposal to provide for an independent Board chair.ForAGAINST — 19 of 20 T. Rowe Price fundsAgainstNot approved, 21.0% support
Autodesk, Inc.2026-06-17Approve, on an advisory (non-binding) basis, the compensation of Autodesk, Inc.'s named executive officers.AgainstFOR — 12 of 12 T. Rowe Price fundsAgainstPassed (calculated), 91.7% support
Tractor Supply Company2026-05-14To approve, on a non-binding, advisory basis, the compensation of the named executive officers of the Company (Say on Pay)AgainstFOR — 19 of 20 T. Rowe Price fundsAgainstApproved, 86.0% support
Burlington Stores, Inc.2026-05-19Approval, on a non-binding advisory basis, of the compensation of Burlington Stores, Inc.'s named executive officers ("Say-On-Pay")AgainstFOR — 19 of 20 T. Rowe Price fundsAgainstPassed (calculated), 88.0% support
Howmet Aerospace Inc.2026-05-19Advisory vote to approve executive compensation.AgainstFOR — 18 of 19 T. Rowe Price fundsAgainstApproved, 71.1% support
Cardinal Health, Inc.2025-11-05To approve, on a non-binding advisory basis, the compensation of our named executive officersAgainstFOR — 18 of 19 T. Rowe Price fundsAgainstApproved, 90.7% support
MSCI Inc.2026-04-21To approve, by advisory vote, our executive compensation.AgainstFOR — 18 of 19 T. Rowe Price fundsAgainstApproved, 93.6% support
Charles River Laboratories International, Inc.2026-05-05Advisory Approval of 2025 Executive Officer CompensationAgainstFOR — 18 of 19 T. Rowe Price fundsAgainstApproved, 93.8% support
RBC Bearings Incorporated2025-09-04To consider a resolution regarding the stockholder advisory vote on named executive officer compensation.AgainstFOR — 18 of 19 T. Rowe Price fundsAgainstApproved, 81.1% support
Thermo Fisher Scientific Inc.2026-05-20An advisory vote to approve named executive officer compensation.AgainstFOR — 36 of 41 T. Rowe Price fundsAgainstNot approved, 31.8% support
Lam Research Corporation2025-11-04Advisory vote to approve the compensation of the named executive officers of Lam Research, or "Say on Pay."AgainstFOR — 11 of 11 T. Rowe Price fundsAgainst—
Arthur J. Gallagher & Co.2026-05-12Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers.AgainstFOR — 11 of 11 T. Rowe Price fundsAgainst—
CBRE Group, Inc.2026-05-21Advisory vote to approve named executive officer compensation for 2025.AgainstFOR — 17 of 18 T. Rowe Price fundsAgainst—
Revolution Medicines, Inc.2026-06-18To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay").AgainstFOR — 17 of 18 T. Rowe Price fundsAgainstApproved, 96.5% support
Insmed Incorporated2026-05-13An advisory vote on the 2025 compensation of our named executive officers.AgainstFOR — 17 of 18 T. Rowe Price fundsAgainstApproved, 87.3% support
Paylocity Holding Corporation2025-12-04Advisory vote to approve the compensation of named executive officers.AgainstFOR — 17 of 18 T. Rowe Price fundsAgainstPassed (calculated), 93.3% support
Ferrari NV2026-04-15Reelect John Elkann as Executive DirectorAgainstFOR — 11 of 11 T. Rowe Price fundsAgainst—
The Bank of New York Mellon Corporation2026-04-14Advisory resolution to approve the 2025 compensation of our named executive officers.AgainstFOR — 16 of 17 T. Rowe Price fundsAgainstPassed (calculated), 55.6% support
Alnylam Pharmaceuticals, Inc.2026-05-20To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.AgainstFOR — 16 of 17 T. Rowe Price fundsAgainst—
HCA Healthcare, Inc.2026-04-23Advisory vote to approve named executive officer compensation.AgainstFOR — 10 of 10 T. Rowe Price fundsAgainstApproved, 93.5% support
Snowflake Inc.2026-06-29To approve, on a non-binding advisory basis, the compensation of our named executive officers.AgainstFOR — 10 of 10 T. Rowe Price fundsAgainstNot approved, 43.6% support
Westinghouse Air Brake Technologies Corporation2026-05-12Approve an advisory (non-binding) resolution to approve the 2025 named executive officer compensation.AgainstFOR — 15 of 16 T. Rowe Price fundsAgainstApproved, 92.3% support
Live Nation Entertainment, Inc.2026-06-11To hold an advisory vote on the company's executive compensation;AgainstFOR — 15 of 16 T. Rowe Price fundsAgainstPassed (calculated), 86.8% support
Rockwell Automation, Inc.2026-02-10To approve, on an advisory basis, the compensation of the Corporation's named executive officers.AgainstFOR — 15 of 16 T. Rowe Price fundsAgainstApproved, 87.2% support
United Therapeutics Corporation2026-06-26Advisory resolution to approve executive compensation.AgainstFOR — 15 of 16 T. Rowe Price fundsAgainstPassed (calculated), 97.1% support
Invesco Ltd.2026-05-21Advisory vote to approve the company's 2025 executive compensation.AgainstFOR — 15 of 16 T. Rowe Price fundsAgainstApproved, 98.6% support
SiTime Corporation2026-05-29To approve, on an advisory basis, the compensation of SiTime's named executive officers as disclosed in SiTime's proxy statement.AgainstFOR — 15 of 16 T. Rowe Price fundsAgainstApproved, 82.1% support
KKR & Co. Inc.2026-05-21An amendment to the Existing Charter to establish stockholders' meetings as the sole mechanism for approval of matters on which holders of common stock are required or permitted to vote.AgainstFOR — 14 of 15 T. Rowe Price fundsAgainst—
KKR & Co. Inc.2026-05-21An amendment to the Existing Charter to grant the Board the sole authority to fill board vacancies and newly created directorships.AgainstFOR — 14 of 15 T. Rowe Price fundsAgainst—
KKR & Co. Inc.2026-05-21Other amendments to the Existing Charter to modernize and streamline the Existing Charter.AgainstFOR — 14 of 15 T. Rowe Price fundsAgainst—
Ecolab Inc.2026-05-07Shareholder Vote on a stockholder proposal regarding an independent board chair policy, if properly presented at the meeting.ForAGAINST — 9 of 9 T. Rowe Price fundsAgainstNot approved, 26.0% support
Veeva Systems Inc.2026-06-17To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Gordon RitterAgainstFOR — 14 of 15 T. Rowe Price fundsAgainstElected, 73.6% support
Veeva Systems Inc.2026-06-17To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Mark CargesAgainstFOR — 14 of 15 T. Rowe Price fundsAgainstElected, 80.0% support
MongoDB, Inc.2026-06-30Approval, on a non-binding advisory basis, of the compensation of our named executive officers.AgainstFOR — 14 of 15 T. Rowe Price fundsAgainstApproved, 89.2% support
UL Solutions Inc.2026-05-20The approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement.AgainstFOR — 14 of 15 T. Rowe Price fundsAgainstPassed (calculated), 99.9% support
Dynatrace, Inc.2025-08-20Non-binding advisory vote on the compensation of Dynatrace's named executive officers.AgainstFOR — 14 of 15 T. Rowe Price fundsAgainstApproved, 91.6% support
Targa Resources Corp.2026-05-21To approve, on an advisory basis, the compensation of the Company's named executive officers for the fiscal year ended December 31, 2025.AgainstFOR — 13 of 14 T. Rowe Price fundsAgainstApproved, 95.3% support
Mueller Industries, Inc.2026-05-07To approve, on an advisory basis by non-binding vote, executive compensation.AgainstFOR — 13 of 14 T. Rowe Price fundsAgainstApproved, 95.3% support
Eli Lilly and Company2026-05-04Shareholder Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair.ForAGAINST — 33 of 40 T. Rowe Price fundsAgainstNot approved, 33.7% support
eBay Inc.2026-06-17Advisory vote to approve named executive officer compensation.AgainstFOR — 12 of 13 T. Rowe Price fundsAgainstApproved, 88.1% support
Ferguson Enterprises Inc.2026-04-30To approve, on an advisory basis, the compensation of the Company's Named Executive Officers for the five-month transition period from August 1, 2025 to December 31, 2025.AgainstFOR — 12 of 13 T. Rowe Price fundsAgainstPassed (calculated), 92.4% support
United Airlines Holdings, Inc.2026-05-19A vote to approve, on a nonbinding advisory basis, the compensation of our named executive officers.AgainstFOR — 12 of 13 T. Rowe Price fundsAgainstApproved, 94.3% support
Samsara Inc.2025-07-29The approval, on a non-binding advisory basis, of the compensation of Samsara Inc.'s named executive officers.AgainstFOR — 12 of 13 T. Rowe Price fundsAgainstApproved, 98.6% support
United Therapeutics Corporation2026-06-26Approval of the United Therapeutics Corporation 2026 Stock Incentive Plan.AgainstFOR — 12 of 13 T. Rowe Price fundsAgainstPassed (calculated), 72.0% support
Permian Resources Corporation2026-05-19To approve the First Amendment to the Permian Resources Corporation 2023 Long Term Incentive Plan.AgainstFOR — 12 of 13 T. Rowe Price fundsAgainstPassed (calculated), 71.8% support
BJ's Wholesale Club Holdings, Inc.2026-06-18Approve, on an advisory (non-binding) basis, the compensation of the named executive officers of BJ's Wholesale Club Holdings, Inc.AgainstFOR — 12 of 13 T. Rowe Price fundsAgainstApproved, 93.0% support
BWX Technologies, Inc.2026-04-30Advisory vote on compensation of our Named Executive Officers.AgainstFOR — 12 of 13 T. Rowe Price fundsAgainstPassed (calculated), 98.5% support
IDEXX Laboratories, Inc.2026-05-12Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three).AgainstFOR — 11 of 12 T. Rowe Price fundsAgainst—
Vistra Corp.2026-04-29To approve, on a non-binding advisory basis, the 2025 compensation of the Company's named executive officers.AgainstFOR — 11 of 12 T. Rowe Price fundsAgainstApproved, 96.9% support
Circle Internet Group, Inc.2026-05-14Advisory Vote to Approve Named Executive Officer CompensationAgainstFOR — 7 of 7 T. Rowe Price fundsAgainstApproved, 99.1% support
Tradeweb Markets Inc.2026-05-19Election of Directors: Catherine JohnsonWithholdFOR — 20 of 24 T. Rowe Price fundsAgainstElected, 97.4% support
Tradeweb Markets Inc.2026-05-19Election of Directors: Daniel MaguireWithholdFOR — 20 of 24 T. Rowe Price fundsAgainstElected, 97.4% support
Tradeweb Markets Inc.2026-05-19Election of Directors: Scott GanelesWithholdFOR — 20 of 24 T. Rowe Price fundsAgainstElected, 96.9% support
Royal Caribbean Cruises Ltd.2026-05-28Advisory approval of the Company's compensation of its named executive officers.AgainstFOR — 10 of 11 T. Rowe Price fundsAgainstPassed (calculated), 96.8% support
Quanta Services, Inc.2026-05-21Approval, by non-binding advisory vote, of the compensation of Quanta's named executive officers for fiscal year 2025;AgainstFOR — 10 of 11 T. Rowe Price fundsAgainst—
Everpure, Inc.2026-06-10An advisory vote on our named executive officer compensation.AgainstFOR — 10 of 11 T. Rowe Price fundsAgainstApproved, 90.4% support
Tapestry, Inc.2025-11-13Advisory vote to approve the Company's executive compensation, as discussed and described in the proxy statement.AgainstFOR — 10 of 11 T. Rowe Price fundsAgainstPassed (calculated), 89.9% support
Nutanix, Inc.2025-12-12Approval, on a non-binding advisory basis, of the compensation of our named executive officers.AgainstFOR — 10 of 11 T. Rowe Price fundsAgainstApproved, 92.1% support
Fair Isaac Corporation2026-03-04To approve the advisory (non-binding) resolution relating to the named executive officer compensation as disclosed in the proxy statement.AgainstFOR — 10 of 11 T. Rowe Price fundsAgainstApproved, 84.9% support
Vertiv Holdings Co.2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Matthew LouieWithholdFOR — 18 of 22 T. Rowe Price fundsAgainstPassed (calculated), 85.6% support
Tesla, Inc.2025-11-06A Tesla proposal for approval of the 2025 CEO Performance Award.AgainstFOR — 22 of 28 T. Rowe Price fundsAgainstApproved, 77.0% support
Roblox Corporation2026-05-28Advisory Vote on the Compensation of our Named Executive Officers.AgainstFOR — 12 of 14 T. Rowe Price fundsAgainstPassed (calculated), 84.2% support
NRG Energy, Inc.2026-04-30To approve, on a non-binding advisory basis, NRG Energy, Inc.'s executive compensation.AgainstFOR — 9 of 10 T. Rowe Price fundsAgainst—
Insulet Corporation2026-05-20To approve, on a non-binding, advisory basis, the compensation of certain executive officers.AgainstFOR — 9 of 10 T. Rowe Price fundsAgainstPassed (calculated), 92.0% support
Corpay, Inc.2026-05-07Shareholder Shareholder proposal regarding an independent Board Chair requirement, if properly presented at the meeting.ForAGAINST — 15 of 19 T. Rowe Price fundsAgainstFailed (calculated), 30.0% support
SharkNinja, Inc.2026-06-18To approve, on a non-binding advisory basis, the compensation of our named executive officers.AgainstFOR — 8 of 9 T. Rowe Price fundsAgainstApproved, 92.6% support
CDW Corporation2026-05-21To approve, on an advisory basis, named executive officer compensation.AgainstFOR — 8 of 9 T. Rowe Price fundsAgainstApproved, 91.1% support
Manhattan Associates, Inc.2026-05-14Non-binding resolution to approve the compensation of the Company's named executive officers.AgainstFOR — 8 of 9 T. Rowe Price fundsAgainstApproved, 89.5% support
Procore Technologies, Inc.2026-06-04To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officersAgainstFOR — 8 of 9 T. Rowe Price fundsAgainstApproved, 63.1% support
Ameriprise Financial, Inc.2026-04-29To approve the compensation of the named executive officers by a nonbinding advisory vote.AgainstFOR — 7 of 8 T. Rowe Price fundsAgainstApproved, 90.6% support
Take-Two Interactive Software, Inc.2025-09-18Approval of an amendment and restatement of the Amended and Restated Take-Two Interactive Software, Inc. 2017 Stock Incentive Plan.AgainstFOR — 7 of 8 T. Rowe Price fundsAgainstApproved, 77.6% support
Interactive Brokers Group, Inc.2026-04-23To approve, by non-binding vote, executive compensation.AgainstFOR — 7 of 8 T. Rowe Price fundsAgainstPassed (calculated), 98.1% support
Medpace Holdings, Inc.2026-05-15To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting.AgainstFOR — 7 of 8 T. Rowe Price fundsAgainst—
Stifel Financial Corp.2026-06-09To approve, on an advisory basis, the compensation of our named executive officers (say on pay).AgainstFOR — 7 of 8 T. Rowe Price fundsAgainstPassed (calculated), 98.1% support
Lazard, Inc.2026-05-21Approval of the amendment to the Lazard Inc. 2018 Incentive Compensation Plan.AgainstFOR — 7 of 8 T. Rowe Price fundsAgainstPassed (calculated), 60.9% support
Stride, Inc.2025-12-04Approval, on a non-binding advisory basis, of the compensation of the named executive officers of the Company;AgainstFOR — 7 of 8 T. Rowe Price fundsAgainstApproved, 81.9% support
Corning Incorporated2026-04-30Shareholder Request to adopt an independent chair policyForAGAINST — 11 of 14 T. Rowe Price fundsAgainstNot approved, 18.2% support
UL Solutions Inc.2026-05-20Election of Directors: Elisabeth TorstadWithholdFOR — 10 of 13 T. Rowe Price fundsAgainst—
UL Solutions Inc.2026-05-20Election of Directors: George A. WilliamsWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.7% support
UL Solutions Inc.2026-05-20Election of Directors: James M. ShannonWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.8% support
UL Solutions Inc.2026-05-20Election of Directors: James P. DolliveWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.6% support
UL Solutions Inc.2026-05-20Election of Directors: Marla C. GottschalkWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.8% support
UL Solutions Inc.2026-05-20Election of Directors: Sally SusmanWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.9% support
DexCom, Inc.2026-05-27To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025.AgainstFOR — 6 of 7 T. Rowe Price fundsAgainstApproved, 88.3% support
Williams-Sonoma, Inc.2026-06-18An advisory vote to approve executive compensationAgainstFOR — 6 of 7 T. Rowe Price fundsAgainstApproved, 84.0% support
Rocket Lab Corporation2026-05-20Election of Class II Director Nominee: To be elected for term expiring in 2029: Edward H. FrankForWITHHOLD — 6 of 7 T. Rowe Price fundsForPassed (calculated), 84.2% support
CDW Corporation2026-05-21Shareholder To consider and act upon the stockholder proposal, if properly presented at the meeting, regarding independent Board chair requirements.ForAGAINST — 6 of 7 T. Rowe Price fundsAgainstNot approved, 42.7% support
NRG Energy, Inc.2026-04-30Shareholder To vote on a stockholder proposal to give shareholders the ability to call for a special shareholder meeting, if properly presented at the meeting.ForAGAINST — 6 of 7 T. Rowe Price fundsAgainstApproved, 55.6% support
CACI International Inc.2025-10-16To approve on a non-binding, advisory basis the compensation of our named executive officers;AgainstFOR — 6 of 7 T. Rowe Price fundsAgainstApproved, 94.8% support
JFrog Ltd.2026-05-20To approve on a nonbinding, advisory basis the compensation paid to us to our named executive officers, as disclosed in the proxy statement.AgainstFOR — 6 of 7 T. Rowe Price fundsAgainstPassed (calculated), 82.0% support
Celsius Holdings, Inc.2026-05-28To elect as directors the ten nominees listed below to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Caroline LevyForAGAINST — 6 of 7 T. Rowe Price fundsForElected, 98.0% support
Celsius Holdings, Inc.2026-05-28To elect as directors the ten nominees listed below to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Cheryl MillerForAGAINST — 6 of 7 T. Rowe Price fundsForElected, 98.8% support
Celsius Holdings, Inc.2026-05-28To elect as directors the ten nominees listed below to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Damon DeSantisForAGAINST — 6 of 7 T. Rowe Price fundsForElected, 96.5% support
Celsius Holdings, Inc.2026-05-28To elect as directors the ten nominees listed below to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Hal KravitzForAGAINST — 6 of 7 T. Rowe Price fundsForElected, 99.4% support
Celsius Holdings, Inc.2026-05-28To elect as directors the ten nominees listed below to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Joyce RussellForAGAINST — 6 of 7 T. Rowe Price fundsForElected, 97.3% support
Celsius Holdings, Inc.2026-05-28To elect as directors the ten nominees listed below to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Nick CastaldoForAGAINST — 6 of 7 T. Rowe Price fundsForElected, 97.7% support
Churchill Downs Incorporated2026-04-21To approve, on a non-binding advisory basis, the Company's executive compensation as disclosed in the proxy statement.AgainstFOR — 6 of 7 T. Rowe Price fundsAgainstApproved, 84.7% support
Seagate Technology Holdings plc2025-10-25Approve, in an Advisory, Non-binding Vote, the Compensation of the Company's Named Executive Officers ("Say-on-Pay").AgainstFOR — 5 of 6 T. Rowe Price fundsAgainst—
BeOne Medicines Ltd.2026-06-11THAT, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, for the fiscal year ended December 31, 2025 be and is hereby approved.AgainstFOR — 5 of 6 T. Rowe Price fundsAgainstApproved, 94.9% support
Iron Mountain Incorporated2026-05-07The approval of a non-binding, advisory resolution approving the compensation of our named executive officers as described in the Iron Mountain Incorporated Proxy Statement.AgainstFOR — 5 of 6 T. Rowe Price fundsAgainstApproved, 96.7% support
Expedia Group, Inc.2026-06-17Approval, on an advisory basis, of the compensation of Expedia Group's named executive officers.AgainstFOR — 5 of 6 T. Rowe Price fundsAgainstApproved, 89.4% support
Twilio Inc.2026-06-16To approve, on a non-binding advisory basis, the compensation of our named executive officers.AgainstFOR — 5 of 6 T. Rowe Price fundsAgainstApproved, 93.7% support
Celestica Inc.2026-05-19To approve, on an advisory basis, the compensation of Celestica Inc.'s named executive officers.AgainstFOR — 5 of 6 T. Rowe Price fundsAgainstPassed (calculated), 96.4% support
Penumbra, Inc.2026-06-18To elect the nominees for Class II director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Arani Bose, M.D.ForWITHHOLD — 3 of 3 T. Rowe Price fundsForElected, 84.9% support
Penumbra, Inc.2026-06-18To elect the nominees for Class II director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Bridget O'RourkeForWITHHOLD — 3 of 3 T. Rowe Price fundsForElected, 95.5% support
Penumbra, Inc.2026-06-18To elect the nominees for Class II director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Surbhi SarnaForWITHHOLD — 3 of 3 T. Rowe Price fundsForElected, 97.3% support
Stifel Financial Corp.2026-06-09To approve the adoption of an amendment to the Stifel Financial Corp. 2001 Incentive Stock Plan (2018 Restatement)AgainstFOR — 5 of 6 T. Rowe Price fundsAgainstPassed (calculated), 69.2% support
Service Corporation International2026-05-06Election of Directors: Marcus A. WattsForAGAINST — 12 of 18 T. Rowe Price fundsForFailed (calculated), 43.5% support
Service Corporation International2026-05-06To approve the 2026 Equity Incentive Plan.AgainstFOR — 12 of 18 T. Rowe Price fundsAgainstApproved, 78.1% support
Rocket Companies, Inc.2026-06-10Election of Class III Directors: Varun KrishnaWithholdFOR — 11 of 18 T. Rowe Price fundsAgainstPassed (calculated), 87.9% support
HEICO Corporation2026-03-13ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Adolfo HenriquesForAGAINST — 4 of 5 T. Rowe Price fundsForElected, 97.5% support
HEICO Corporation2026-03-13ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Carol F. FineForAGAINST — 4 of 5 T. Rowe Price fundsForElected, 98.8% support
HEICO Corporation2026-03-13ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Dr. Alan SchriesheimForAGAINST — 4 of 5 T. Rowe Price fundsForElected, 73.2% support
HEICO Corporation2026-03-13ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Julie NeitzelForAGAINST — 4 of 5 T. Rowe Price fundsForElected, 98.4% support
HEICO Corporation2026-03-13ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Mark H. HildebrandtForAGAINST — 4 of 5 T. Rowe Price fundsForElected, 73.7% support
HEICO Corporation2026-03-13ELECTION OF HEICO'S BOARD OF DIRECTORS FOR THE ENSUING YEAR: Thomas M. CulliganForAGAINST — 4 of 5 T. Rowe Price fundsForElected, 98.3% support
BeOne Medicines Ltd.2026-06-11THAT Mr. John V. Oyler be and is hereby re-elected to serve as Chairman of the Board of Directors of the Company for a term extending until completion of the 2027 annual general meeting.AgainstFOR — 4 of 5 T. Rowe Price fundsAgainstElected, 98.8% support
BeOne Medicines Ltd.2026-06-11THAT, on an advisory basis, the Swiss Statutory Compensation Report for the fiscal year ended December 31, 2025 be and is hereby approved.AgainstFOR — 4 of 5 T. Rowe Price fundsAgainstApproved, 95.6% support
BeOne Medicines Ltd.2026-06-11THAT, the maximum aggregate compensation for the Board of Directors for the period between the 2026 annual general meeting and the 2027 annual general meeting, be and is hereby approved.AgainstFOR — 4 of 5 T. Rowe Price fundsAgainstApproved, 95.4% support
Carnival Corporation2026-04-17To hold a (non-binding) advisory vote to approve executive compensation.AgainstFOR — 4 of 5 T. Rowe Price fundsAgainstPassed (calculated), 96.8% support
Okta, Inc.2026-06-18To approve an amendment to our 2017 Equity Incentive Plan.AgainstFOR — 4 of 5 T. Rowe Price fundsAgainstApproved, 70.6% support
Hyatt Hotels Corporation2026-05-20Approval, on an advisory basis, of the compensation paid to our named executive officers as disclosed pursuant to the Securities and Exchange Commission's compensation disclosure rules.AgainstFOR — 4 of 5 T. Rowe Price fundsAgainstApproved, 99.5% support
Somnigroup International, Inc.2026-05-13ADVISORY VOTE TO APPROVE THE COMPENSATION OF NAMED EXECUTIVE OFFICERS; ANDAgainstFOR — 4 of 5 T. Rowe Price fundsAgainstPassed (calculated), 58.1% support
Dutch Bros Inc.2026-05-13Election of Directors: Todd PenegorForAGAINST — 10 of 17 T. Rowe Price fundsForElected, 91.7% support
Dutch Bros Inc.2026-05-13Election of Directors: Travis BoersmaForAGAINST — 10 of 17 T. Rowe Price fundsForElected, 95.6% support
Clean Harbors, Inc.2026-05-20To elect four (4) Class I members of the Board of Directors of the Company to serve until the 2029 Annual Meeting of Shareholders: John R. WelchWithholdFOR — 6 of 9 T. Rowe Price fundsAgainstPassed (calculated), 98.5% support
Clean Harbors, Inc.2026-05-20To elect four (4) Class I members of the Board of Directors of the Company to serve until the 2029 Annual Meeting of Shareholders: Shelley Stewart, Jr.WithholdFOR — 6 of 9 T. Rowe Price fundsAgainstPassed (calculated), 99.4% support
Domino's Pizza, Inc.2026-04-21Shareholder Shareholder proposal regarding an independent board chair requirement.ForAGAINST — 7 of 12 T. Rowe Price fundsAgainstNot approved, 39.9% support
Fastenal Company2026-04-23Shareholder Shareholder proposal relating to an EEO-1 reporting disclosure policy, if properly presented at the annual meeting.AgainstFOR — 3 of 4 T. Rowe Price funds—Not approved, 23.0% support
Carnival Corporation2026-04-17To hold a (non-binding) advisory vote to approve the Carnival plc Directors' Remuneration Report (in accordance with legal requirements applicable to UK companies).AgainstFOR — 3 of 4 T. Rowe Price fundsAgainstPassed (calculated), 97.2% support
Hyatt Hotels Corporation2026-05-20Shareholder Stockholder proposal requesting the issuance of a report analyzing whether Hyatt could disclose its overall plastics use.AgainstFOR — 3 of 4 T. Rowe Price fundsForNot approved, 0.4% support
Core & Main, Inc.2026-06-23Election of Directors: Bhavani AmirthalingamForWITHHOLD — 3 of 4 T. Rowe Price fundsForElected, 95.4% support
Core & Main, Inc.2026-06-23Election of Directors: Margaret M. NewmanForWITHHOLD — 3 of 4 T. Rowe Price fundsForElected, 94.6% support
Core & Main, Inc.2026-06-23Election of Directors: Orvin T. KimbroughForWITHHOLD — 3 of 4 T. Rowe Price fundsForElected, 64.2% support
Impinj, Inc.2026-05-28Election of Directors: Steve SanghiForAGAINST — 7 of 13 T. Rowe Price fundsForElected, 68.1% support
Symbotic Inc.2026-03-05To approve an advisory vote on the compensation paid to our named executive officers.AgainstFOR — 2 of 3 T. Rowe Price fundsAgainstPassed (calculated), 99.0% support

Download all 239 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 94.7% of this fund’s 3,708 such votes could be given a sector; the other 197 (5.3%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Consumer Discretionary965505.2%
Technology834465.5%
Industrials515163.1%
Health Care448122.7%
Finance41261.5%
Energy8600.0%
Utilities8411.2%
Real Estate6600.0%
Miscellaneous3700.0%
Consumer Staples3000.0%
Basic Materials2414.2%
Telecommunications1000.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections2,6590
Audit-related3360
Say-on-Pay3280
Corporate Governance16260
Compensation1073
Capital Structure560
Other Social Issues2827
Environment or Climate2323
Shareholder Rights and Defenses167
Human Rights or Human Capital/workforce1212

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Apple Inc.February 24, 2026$161M121
NVIDIA CorporationJune 24, 2026$142M164
Microsoft CorporationDecember 5, 2025$131M216
Meta Platforms, Inc.May 27, 2026$100M229
Amazon.com, Inc.May 20, 2026$77M174
Broadcom Inc.April 20, 2026$64M100
Eli Lilly and CompanyMay 4, 2026$53M102
Visa Inc.January 27, 2026$35M184

Notable votes against management

MeetingCompanyProposalFundMgmt
February 24, 2026Apple Inc.A shareholder proposal entitled "China Entanglement Audit" Shareholder proposalAgainstFor
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposalForAgainst
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationEuropean Security Program Censorship Risk Audit Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationReport on Risks of Censorship in Generative Artificial Intelligence Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding report on Al data usage oversight. Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposalAgainstFor
May 4, 2026Eli Lilly and CompanyShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalForAgainst
May 4, 2026Eli Lilly and CompanyShareholder proposal to prepare an annual lobbying report. Shareholder proposalAgainstFor
January 27, 2026Visa Inc.Shareholder proposal requesting the Board of Directors to adopt a policy for an independent chair. Shareholder proposalForAgainst

Search this fund’s votes by company

3,737 ballot items at 340 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, T. Rowe Price Tax-Efficient Equity Fund (PREFX) voted at 340 shareholder meetings of 332 companies, on 3,737 ballot items in all. Where management made a recommendation, the fund followed it on 96.4% of the items and voted against it 132 times. Its most frequent area of disagreement was corporate governance (60 of its votes against management). It voted FOR 18.7% of the 134 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals less often than T. Rowe Price's funds as a whole (86.9% against 93.7%). It voted differently from most T. Rowe Price funds on 239 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.